Jean-François Rosier

477 total citations
14 papers, 389 citations indexed

About

Jean-François Rosier is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jean-François Rosier has authored 14 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean-François Rosier's work include Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Jean-François Rosier is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Jean-François Rosier collaborates with scholars based in Belgium, United States and Netherlands. Jean-François Rosier's co-authors include Pierre Scalliet, Vincent Grégoire, M. Octave-Prignot, Marc Hamoir, Walter N. Hittelman, L. Milas, V. Grégoire, L. Böhm, Niels Neymark and Louis Eeckhoudt and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Jean-François Rosier

14 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean-François Rosier Belgium 11 154 149 135 89 65 14 389
Célia M. Viégas Brazil 10 283 1.8× 158 1.1× 134 1.0× 53 0.6× 71 1.1× 19 477
Matthew E. Witek United States 14 146 0.9× 214 1.4× 134 1.0× 111 1.2× 177 2.7× 50 578
Atsushi Musha Japan 12 214 1.4× 100 0.7× 130 1.0× 42 0.5× 99 1.5× 47 366
Roger Tell Sweden 10 60 0.4× 166 1.1× 95 0.7× 73 0.8× 49 0.8× 22 390
Heikki Joensuu Finland 9 235 1.5× 163 1.1× 180 1.3× 79 0.9× 62 1.0× 11 551
A Berthelsen Denmark 8 169 1.1× 154 1.0× 164 1.2× 46 0.5× 102 1.6× 12 420
K. M. Stenson United States 7 226 1.5× 193 1.3× 374 2.8× 97 1.1× 269 4.1× 10 582
Alicia Marín Spain 8 80 0.5× 76 0.5× 34 0.3× 42 0.5× 69 1.1× 15 311
K. Matsuura Japan 12 246 1.6× 107 0.7× 92 0.7× 91 1.0× 121 1.9× 37 483
Eloy Roman United States 8 68 0.4× 44 0.3× 66 0.5× 41 0.5× 62 1.0× 11 342

Countries citing papers authored by Jean-François Rosier

Since Specialization
Citations

This map shows the geographic impact of Jean-François Rosier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-François Rosier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-François Rosier more than expected).

Fields of papers citing papers by Jean-François Rosier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-François Rosier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-François Rosier. The network helps show where Jean-François Rosier may publish in the future.

Co-authorship network of co-authors of Jean-François Rosier

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-François Rosier. A scholar is included among the top collaborators of Jean-François Rosier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-François Rosier. Jean-François Rosier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ruysscher, Dirk De, C. Dehing, Søren M. Bentzen, et al.. (2007). Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Annals of Oncology. 18(5). 909–916. 40 indexed citations
2.
Horsman, Michael R., L. Böhm, Geoffrey P. Margison, et al.. (2006). Tumor radiosensitizers—current status of development of various approaches: Report of an International Atomic Energy Agency meeting. International Journal of Radiation Oncology*Biology*Physics. 64(2). 551–561. 30 indexed citations
3.
Rosier, Jean-François, et al.. (2004). Role of 2′-2′ difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas. Radiotherapy and Oncology. 70(1). 55–61. 9 indexed citations
4.
Cardoen, S., Eric Van Den Neste, Caroline Smal, et al.. (2004). Effects of 2‐Chloro‐2′‐Deoxyadenosine on the Cell Cycle in the Human Leukemia EHEB Cell Line. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1425–1429. 5 indexed citations
5.
Rosier, Jean-François, Lucienne Michaux, Geneviève Ameye, et al.. (2003). The radioenhancement of two human head and neck squamous cell carcinomas by 2′-2′ difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 527(1-2). 15–26. 12 indexed citations
6.
Grégoire, Vincent, K. Kian Ang, Jean-François Rosier, et al.. (2002). A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma. Radiotherapy and Oncology. 63(2). 187–193. 19 indexed citations
7.
Grégoire, Vincent, Jean-François Rosier, Marc De Bast, et al.. (2002). Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro. Radiotherapy and Oncology. 63(3). 329–338. 26 indexed citations
8.
Cardoen, S., Eric Van Den Neste, Caroline Smal, et al.. (2001). Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.. PubMed. 7(11). 3559–66. 20 indexed citations
9.
Gueulette, John, Jacobus Slabbert, L. Böhm, et al.. (2001). Proton RBE for early intestinal tolerance in mice after fractionated irradiation. Radiotherapy and Oncology. 61(2). 177–184. 39 indexed citations
10.
11.
Grégoire, Vincent, Marc Hamoir, Jean-François Rosier, et al.. (1999). Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. Radiotherapy and Oncology. 53(1). 1–13. 32 indexed citations
12.
Grégoire, V., Walter N. Hittelman, Jean-François Rosier, & L. Milas. (1999). Chemo-radiotherapy: radiosensitizing nucleoside analogues (review).. Oncology Reports. 6(5). 949–57. 54 indexed citations
13.
Rosier, Jean-François, et al.. (1998). Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation. Radiotherapy and Oncology. 48(2). 175–183. 89 indexed citations
14.
Rosier, Jean-François, M. Beauduin, B. Coster, et al.. (1997). The role of gemcitabine-induced cell cycle synchronization in radiosensitization of A SCC61 human head & neck squamous carcinoma cell (HNSCC) line. European Journal of Cancer. 33. S23–S24. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Célia M. Viégas Breakdown of academic impact, for papers by Matthew E. Witek Breakdown of academic impact, for papers by Atsushi Musha Breakdown of academic impact, for papers by Roger Tell Breakdown of academic impact, for papers by Heikki Joensuu Breakdown of academic impact, for papers by A Berthelsen Breakdown of academic impact, for papers by K. M. Stenson Breakdown of academic impact, for papers by Alicia Marín Breakdown of academic impact, for papers by K. Matsuura Breakdown of academic impact, for papers by Eloy Roman
Rankless by CCL
2026